Globus Medical (GMED) Shares Outstanding (2011 - 2026)

Globus Medical (GMED) has 16 years of Shares Outstanding data on file, last reported at $113.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.27% year-over-year to $113.2 million; the trailing twelve-month figure through Mar 2026 stood at $113.2 million (changed 0.27% YoY), and the FY2025 full-year result was $22.4 million, down 80.49% from the prior year.
• Shares Outstanding for Q1 2026 stood at $113.2 million, up from $22.4 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $118.2 million in Q3 2023 and bottomed at $22.4 million in Q4 2022.
• The 5-year median for Shares Outstanding is $77.9 million (2023), against an average of $73.2 million.
• The widest annual swing landed in 2024, when Shares Outstanding plunged 81.02%; it then jumped 400.11% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $77.8 million in 2022, then jumped by 46.48% to $113.9 million in 2023, then gained by 0.95% to $115.0 million in 2024, then slumped by 80.49% to $22.4 million in 2025, then soared by 404.84% to $113.2 million in 2026.
• The last three Shares Outstanding figures came in at $113.2 million (Q1 2026), $22.4 million (Q4 2025), and $112.2 million (Q3 2025), per Business Quant data.

Peer Comparison